
Molina Healthcare (MOH) Stock Forecast & Price Target
Molina Healthcare (MOH) Analyst Ratings
Bulls say
Molina Healthcare is facing challenges in generating potential upside, with their current conservative assumptions in 2026 guidance not aligning with industry views and market expectations. The company's recent decision to exit MAPD and focus primarily on the Medicaid and Marketplace segments raises concerns, especially with rate pressure in Medicaid and uncertainties around D-SNP contracts. As such, the target price for the company has been lowered to $144 to reflect this cautionary stance.
Bears say
Molina Healthcare is facing challenges with continued medical cost pressures and uncertainties in key areas such as marketplace MLR progression and Medicaid trend assumptions, leading to a negative outlook for the company. Despite a strong presence in government-sponsored healthcare, the company's guidance for 2026 is difficult to support, with EPS estimates well below initial investor expectations. Risks to the company's financials include potential declines in membership and higher-than-anticipated costs for upcoming contracts.
This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Molina Healthcare (MOH) Analyst Forecast & Price Prediction
Start investing in Molina Healthcare (MOH)
Order type
Buy in
Order amount
Est. shares
0 shares